Publications

Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo

 98
Combination antiretroviral therapy and MCL-1 inhibition mitigate HTLV-1 infection in vivo

Tags:

Previous Article

Liver identified as driver of body wasting in cancer

Next Article

Combination antiretroviral therapy!

Related Posts

p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosis

p53 induces circFRMD4A to suppress cancer development t...

 94

The temporal dynamics of the gut mycobiome and its association with cardiometabolic health in a nationwide cohort of 12,641 Chinese adults

The temporal dynamics of the gut mycobiome and its asso...

 97

The adaptive value of stubborn goals

The adaptive value of stubborn goals

 58